Kress Jean-Paul 4
4 · Vor Biopharma Inc. · Filed Jun 27, 2025
Insider Transaction Report
Form 4
Kress Jean-Paul
DirectorCEO and Chairman
Transactions
- Award
Employee Stock Option (right to buy)
2025-06-26+83,296,638→ 83,296,638 totalExercise: $0.89Exp: 2035-06-25→ Common Stock (83,296,638 underlying)
Footnotes (1)
- [F1]1/4th of the shares underlying the option vest on June 26, 2026, with the remainder vesting in equal monthly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.